Holen Sie sich die Stockscreener-App
2.05
3.30%
-0.07
Handel nachbörslich:
2.06
0.01
+0.49%
Schlusskurs vom Vortag:
$2.12
Offen:
$2.12
24-Stunden-Volumen:
5.55M
Relative Volume:
0.99
Marktkapitalisierung:
$1.06B
Einnahmen:
$1.70B
Nettoeinkommen (Verlust:
$-123.70M
KGV:
-7.6981
EPS:
-0.2663
Netto-Cashflow:
$-178.21M
1W Leistung:
-2.84%
1M Leistung:
-21.15%
6M Leistung:
-17.00%
1J Leistung:
-53.83%
1-Tages-Spanne:
$2.04
$2.1365
1-Wochen-Bereich:
$2.03
$2.1899
52-Wochen-Spanne:
$2.03
$4.80
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
2.05 | 1.10B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
278.91 | 247.49B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.02 | 96.10B | 402.11B | 1.73B | 7.81B | 1.3789 |
|
CI
Cigna Group
|
294.73 | 75.83B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
330.25 | 71.87B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
175.40 | 21.81B | 126.36B | 1.30B | 1.55B | 10.67 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Clover Health stock hits 52-week low at 2.12 USD By Investing.com - Investing.com Nigeria
Buy Signal: Is Clover Health Investments Corp showing insider buyingStock Surge & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Clover Health Investments (NASDAQ:CLOV) Downgraded by Wall Street Zen to Sell - MarketBeat
Not Many Are Piling Into Clover Health Investments, Corp. (NASDAQ:CLOV) Just Yet - 富途牛牛
Clover Health Investments, Corp. (NASDAQ:CLOV) Receives Average Rating of "Hold" from Analysts - MarketBeat
Can Clover Health Stock Rebound as Profitability Deadline Nears? - AD HOC NEWS
Dow Update: Does Clover Health Investments Corp have a competitive edge2025 Trade Ideas & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Clover Health Investments (NASDAQ:CLOV) Reaches New 52-Week LowTime to Sell? - MarketBeat
Clover Health jumps 19%; options activity could be why - MSN
Clover Health stock hits 52-week low at 2.12 USD - Investing.com
Clover Health On Track To Hit First Full-Year Profit In 2026 - RTTNews
Layoff Watch: Does Clover Health Investments Corp offer margin of safety2025 Market WrapUp & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - 富途牛牛
Flat Medicare Advantage Rates Put Clover Health Margins Under Fresh Scrutiny - Yahoo Finance
Clover Health rises as Medicare Advantage enrollments climb 53% - MSN
Clover Health Investments, Corp. to Release Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Quiver Quantitative
Clover Health (CLOV) Upgraded to Buy Amid Profitability Prospects - GuruFocus
Clover Health Investments (NASDAQ:CLOV) Trading Down 5.8%Time to Sell? - MarketBeat
Clover Health (CLOV) Slides As Trump Medicare Advantage Shock And UnitedHealth Earnings Hit Insurer Sentiment - Benzinga
Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 29.85% Potential Upside in Healthcare Plans - DirectorsTalk Interviews
Clover Health Is Undervalued With Clear Signs Of A 2026 Profit Breakout (NASDAQ:CLOV) - Seeking Alpha
Clover Health Balances Customer Growth And Cash Flow Against Revenue Pressure - Sahm
Investor Mood: Is NeuroSense Therapeutics Ltd stock a buy or sellEarnings Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Clover Health (CLOV): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
A Look At Clover Health (CLOV) Valuation After Optimistic Analyst Views And 2026 Profitability Target - simplywall.st
Clover Health CEO Reynoso sells $11860 in shares By Investing.com - Investing.com Canada
Clover Health CEO Reynoso sells $11860 in shares - Investing.com
Clover Health (CLOV) Stock Trades Up, Here Is Why - The Globe and Mail
Clover Health Shares Show Momentum as Analyst Reiterates Confidence - AD HOC NEWS
CLOV Analyst Rating: Canaccord Genuity Maintains 'Buy' with Pric - GuruFocus
Canaccord Genuity Group Reiterates Buy Rating for Clover Health Investments (NASDAQ:CLOV) - MarketBeat
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now - TradingView
CLOV reports MA membership growth, signals GAAP profitability in 2026 - MSN
Clover Health shares jump on 53% surge in Medicare Advantage membership - MSN
Published on: 2026-01-17 22:01:13 - baoquankhu1.vn
Traders Buy Large Volume of Put Options on Clover Health Investments (NASDAQ:CLOV) - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 - The Globe and Mail
Clover Health Investments (NASDAQ:CLOV) Shares Down 4.8%Here's Why - MarketBeat
Clover Health Investments (CLOV) Is Up 12.4% After Surging Medicare Advantage Growth And 2026 Profit Outlook – Has The Bull Case Changed? - Yahoo Finance
Clover Health Investments, Corp. (CLOV): A Bull Case Theory - Finviz
A Look At Clover Health (CLOV) Valuation After Membership Surge And First Profit Outlook - Yahoo Finance
Clover Health reports 53% Medicare Advantage growth, eyes 2026 profitability - Investing.com Nigeria
Clover Health (CLOV) Sees 11% Stock Surge on Medicare Advantage Growth - GuruFocus
Clover Health (CLOV) Reports Significant Membership Growth for 2 - GuruFocus
Clover Health (CLOV) Shares Skyrocket, What You Need To Know - Finviz
Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November - Benzinga
ex991-pressreleasedatedj.htm - SEC.gov
Clover Health Investments (NASDAQ:CLOV) Shares Gap UpTime to Buy? - MarketBeat
Clover Health Stock Is Climbing Wednesday: What's Going On? - Benzinga
Clover Health stock soars after 53% Medicare Advantage membership growth - Investing.com
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
1.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):